tiprankstipranks
Immix Biopharma, Inc. (IMMX)
NASDAQ:IMMX
US Market
IMMX
Immix Biopharma
RESEARCH TOOLSreports
Want to see IMMX full AI Analyst Report?

Immix Biopharma (IMMX) Income Statement

194 Followers

Immix Biopharma Income Statement

Last quarter (Q4 2025), Immix Biopharma's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Immix Biopharma's net income was $-10.69M. See Immix Biopharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -364.50K$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 26.85M$ 22.67M$ 16.14M$ 8.22M$ 1.35M
Depreciation and Amortization
$ 364.50K$ 115.39K$ 5.47K$ 2.13K$ 2.47K
EBITDA
$ -26.85M$ -22.56M$ -16.14M$ -8.22M$ -24.20M
Operating Income
$ -27.21M$ -22.67M$ -16.14M$ -8.22M$ -1.35M
Other Income/Expenses
$ -2.19M$ 1.02M$ 572.01K$ -497.00$ -23.03M
Pretax Income
$ -29.40M$ -21.66M$ -15.57M$ -8.22M$ -24.38M
Net Income
$ -29.44M$ -21.61M$ -15.43M$ -8.23M$ -24.38M
Per Share Metrics
Basic EPS
$ -0.89$ -0.76$ -0.89$ -0.59$ -6.64
Diluted EPS
$ -0.89$ -0.76$ -0.89$ -0.59$ -6.64
Weighted Average Shares Outstanding
 32.97M 28.29M 17.34M 13.89M 3.67M
Weighted Average Shares Outstanding (Diluted)
 32.97M 28.29M 17.34M 13.89M 3.67M
Currency in USD

Immix Biopharma Earnings and Revenue History